Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 13/20 | 0.49 |
| ▸ | ACACA | Q13085 | 13/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27207666 | 0.93 | ACACB (0.48) | ACACBACACATHRBCHRM2CHRM4 | |
| SCHEMBL2441549 | 0.86 | ACACB (0.37) | ACACBACACATHRB | |
| SCHEMBL31275241 | 0.84 | ACACB (0.49) | ACACBACACATHRB | |
| SCHEMBL4609825 | 0.83 | ACACB (0.51) | ACACBACACATHRBCHRM2CHRM4 | |
| SCHEMBL4609822 | 0.83 | ACACB (0.51) | ACACBACACATHRBCHRM2CHRM4 | |
| Spirotetramat SCHEMBL27350845 | 0.81 | ACACB (0.49) | ACACBACACATHRBKDM4E | |
| Spirotetramat SCHEMBL337030 | 0.81 | ACACB (0.49) | ACACBACACATHRBKDM4E | |
| Spirotetramat SCHEMBL26389 | 0.81 | ACACB (0.49) | ACACBACACATHRBKDM4E | |
| Spirotetramat SCHEMBL14855635 | 0.81 | ACACB (0.49) | ACACBACACATHRBKDM4E | |
| Spirotetramat SCHEMBL12022413 | 0.81 | ACACB (0.49) | ACACBACACATHRBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11970518-B2 | Compositions and methods for the encapsulation and scalable delivery of agrochemicals | AGROSPHERES, INC. (US) | 2024-04-30 | — | — | US | disclosed |
| US-11690379-B2 | Aqueous insecticidal composition and methods of use thereof | VALENT U.S.A., LLC (US) | 2023-07-04 | — | — | US | disclosed |
| WO-2021154628-A1 | AN AQUEOUS INSECTICIDAL COMPOSITION AND METHODS OF USE THEREOF | VALENT U.S.A. LLC (US) | 2021-08-05 | — | — | WO | disclosed |
| US-20210227829-A1 | AQUEOUS INSECTICIDAL COMPOSITION AND METHODS OF USE THEREOF | VALENT USA LLC (US) | 2021-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11970518-B2 | Compositions and methods for the encapsulation and scalable delivery of agrochemicals | RCC1, ACHE, ALPG | ACACB 153/4885ACACA 671/4885THRB 4733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.